1. 53BP1 depletion causes PARP inhibitor resistance in ATM-deficient breast cancer cells. Issue 1 (December 2016) Authors: Hong, Ruoxi; Ma, Fei; Zhang, Weimin; Yu, Xiying; Li, Qing; Luo, Yang; Zhu, Changjun; Jiang, Wei; Xu, Binghe Journal: BMC cancer Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Administration of Lapatinib with Food Increases Its Plasma Concentration in Chinese Patients with Metastatic Breast Cancer: A Prospective Phase II Study. (14th February 2020) Authors: Xu, Fei; Lee, Kaping; Xia, Wen; Liao, Hai; Lu, Qianyi; Zhang, Jingmin; Yuan, Huimin; Zhang, Kai; Zheng, Qiufan; Qin, Ge; Zhai, Qinglian; Hong, Ruoxi; Jiang, Kuikui; Li, Yuan; Wang, Shusen Journal: Oncologist Issue: Volume 25:Number 9(2020) Page Start: e1286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Analysis of the activity and safety of weekly low‐dose bevacizumab‐based regimens in heavily pretreated patients with metastatic breast cancer. Issue 5 (25th March 2018) Authors: Zhai, Xiaoyu; Hong, Ruoxi; Fan, Ying; Yuan, Peng; Wang, Jiayu; Sang, Die; Chen, Junlin; Zhao, Chunying; Ou, Kaiping; Ma, Fei; Xu, Binghe Journal: Thoracic cancer Issue: Volume 9:Issue 5(2018) Page Start: 613 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Breast cancer: an up‐to‐date review and future perspectives. Issue 10 (8th September 2022) Authors: Hong, Ruoxi; Xu, Binghe Journal: Cancer communications Issue: Volume 42:Issue 10(2022) Page Start: 913 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. CDK4/6 inhibitor palbociclib enhances the effect of pyrotinib in HER2-positive breast cancer. (10th April 2019) Authors: Zhang, Kai; Hong, Ruoxi; Kaping, Lee; Xu, Fei; Xia, Wen; Qin, Ge; Zheng, Qiufan; Lu, Qianyi; Zhai, Qinglian; Shi, Yanxia; Yuan, Zhongyu; Deng, Wuguo; Chen, Miao; Wang, Shusen Journal: Cancer letters Issue: Volume 447(2019) Page Start: 130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in the Chinese population. (1st January 2021) Authors: Wang, Liye; Zhai, Qinglian; Lu, Qianyi; Lee, Kaping; Zheng, Qiufan; Hong, Ruoxi; Wang, Shusen Journal: Annals of medicine Issue: Volume 53:Number 1(2021) Page Start: 1358 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Cover Image: Metronomic chemotherapy of cyclophosphamide plus methotrexate for advanced breast cancer: Real‐world data analyses and experience of one center. Issue 5 (20th May 2020) Authors: Lu, Qianyi; Lee, Kaping; Xu, Fei; Xia, Wen; Zheng, Qiufan; Hong, Ruoxi; Jiang, Kuikui; Zhai, Qinglian; Li, Yuan; Shi, Yanxia; Yuan, Zhongyu; Wang, Shusen Journal: Cancer communications Issue: Volume 40:Issue 5(2020) Page Start: i Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Efficacy of Oral Etoposide in Pretreated Metastatic Breast Cancer. Issue 17 (May 2015) Authors: Yuan, Peng; Di, Lijun; Zhang, Xiaohui; Yan, Min; Wan, Donggui; Li, Li; Zhang, Yongqiang; Cai, Jufen; Dai, Hong; Zhu, Qi; Hong, Ruoxi; Xu, Binghe; Kichenadasse., Ganessan Journal: Medicine Issue: Volume 94:Issue 17(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy of Oral Etoposide in Pretreated Metastatic Breast Cancer: A Multicenter Phase 2 Study. Issue 17 (May 2015) Authors: Yuan, Peng; Di, Lijun; Zhang, Xiaohui; Yan, Min; Wan, Donggui; Li, Li; Zhang, Yongqiang; Cai, Jufen; Dai, Hong; Zhu, Qi; Hong, Ruoxi; Xu, Binghe Other Names: Kichenadasse. Ganessan section editor. Journal: Medicine Issue: Volume 94:Issue 17(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Erratum to: 53BP1 depletion causes PARP inhibitor resistance in ATM-deficient breast cancer cells. Issue 1 (December 2016) Authors: Hong, Ruoxi; Ma, Fei; Zhang, Weimin; Yu, Xiying; Li, Qing; Luo, Yang; Zhu, Changjun; Xu, Binghe; Jiang, Wei Journal: BMC cancer Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗